RankingsPricing
  1. JP-listed companies
  2. COSMOS Pharmaceutical Corporation
  3. Financials
  4. Pretax margin (%)

COSMOS Pharmaceutical Corporation【JP:3349】

Market cap
¥570B
P/E ratio
18.2x
SummaryFinancialsDividendsHistoryOwnershipWorkforce
Period EndPretax margin (%) YoY (%)
May 31, 20254.3+20.06%
May 31, 20243.6-11.08%
May 31, 20234-8.11%
May 31, 20224.4-11.82%
May 31, 20214.9+6.97%
May 31, 20204.6+3.27%
May 31, 20194.5-1.33%
May 31, 20184.5-7.47%
May 31, 20174.9+5.74%
May 31, 20164.6-0.69%
May 31, 20154.7-4.79%
May 31, 20144.9-4.02%
May 31, 20135.1-2.02%
May 31, 20125.2+11.46%
May 31, 20114.7

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating income Operating expenses Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareAdjusted DPSEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)